Copyright Reports & Markets. All rights reserved.

Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size, Status and Forecast 2020-2026

Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Mycoplasma Pneumoniae
    • 1.4.3 Streptococcus Pneumoniae
    • 1.4.4 Haemophilus Influenzae
    • 1.4.5 Moraxella Catarrhalis
    • 1.4.6 Chlamydia Pneumoniae
    • 1.4.7 Klebsiella Pneumoniae
    • 1.4.8 Staphylococcus Aureus
    • 1.4.9 Others
  • 1.5 Market by Application
    • 1.5.1 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Application: 2020 VS 2026
    • 1.5.2 Infant (<1 year old)
    • 1.5.3 Children and Adolescents (1-25 years old)
    • 1.5.4 Adult (25-65 years old)
    • 1.5.5 Senior citizens (over 65 years old)
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends by Regions

  • 2.1 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Perspective (2015-2026)
  • 2.2 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Growth Trends by Regions
    • 2.2.1 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Historic Market Share by Regions (2015-2020)
    • 2.2.3 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Growth Strategy
    • 2.3.6 Primary Interviews with Key LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Players by Market Size
    • 3.1.1 Global Top LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Players by Revenue (2015-2020)
    • 3.1.2 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Concentration Ratio
    • 3.2.1 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Revenue in 2019
  • 3.3 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Key Players Head office and Area Served
  • 3.4 Key Players LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product Solution and Service
  • 3.5 Date of Enter into LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Historic Market Size by Type (2015-2020)
  • 4.2 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Forecasted Market Size by Type (2021-2026)

5 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Breakdown Data by Application (2015-2026)

  • 5.1 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application (2015-2020)
  • 5.2 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size (2015-2020)
  • 6.2 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Key Players in North America (2019-2020)
  • 6.3 North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type (2015-2020)
  • 6.4 North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size (2015-2020)
  • 7.2 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Key Players in Europe (2019-2020)
  • 7.3 Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type (2015-2020)
  • 7.4 Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application (2015-2020)

8 China

  • 8.1 China LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size (2015-2020)
  • 8.2 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Key Players in China (2019-2020)
  • 8.3 China LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type (2015-2020)
  • 8.4 China LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size (2015-2020)
  • 9.2 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Key Players in Japan (2019-2020)
  • 9.3 Japan LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type (2015-2020)
  • 9.4 Japan LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size (2015-2020)
  • 10.2 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type (2015-2020)
  • 10.4 Southeast Asia LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application (2015-2020)

11 India

  • 11.1 India LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size (2015-2020)
  • 11.2 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Key Players in India (2019-2020)
  • 11.3 India LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type (2015-2020)
  • 11.4 India LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size (2015-2020)
  • 12.2 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type (2015-2020)
  • 12.4 Central & South America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 CapitalBio
    • 13.1.1 CapitalBio Company Details
    • 13.1.2 CapitalBio Business Overview and Its Total Revenue
    • 13.1.3 CapitalBio LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
    • 13.1.4 CapitalBio Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2015-2020))
    • 13.1.5 CapitalBio Recent Development
  • 13.2 BGI
    • 13.2.1 BGI Company Details
    • 13.2.2 BGI Business Overview and Its Total Revenue
    • 13.2.3 BGI LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
    • 13.2.4 BGI Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2015-2020)
    • 13.2.5 BGI Recent Development
  • 13.3 Eiken Chemical
    • 13.3.1 Eiken Chemical Company Details
    • 13.3.2 Eiken Chemical Business Overview and Its Total Revenue
    • 13.3.3 Eiken Chemical LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
    • 13.3.4 Eiken Chemical Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2015-2020)
    • 13.3.5 Eiken Chemical Recent Development
  • 13.4 Deaou Biotechnology
    • 13.4.1 Deaou Biotechnology Company Details
    • 13.4.2 Deaou Biotechnology Business Overview and Its Total Revenue
    • 13.4.3 Deaou Biotechnology LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
    • 13.4.4 Deaou Biotechnology Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2015-2020)
    • 13.4.5 Deaou Biotechnology Recent Development
  • 13.5 Singuway
    • 13.5.1 Singuway Company Details
    • 13.5.2 Singuway Business Overview and Its Total Revenue
    • 13.5.3 Singuway LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
    • 13.5.4 Singuway Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2015-2020)
    • 13.5.5 Singuway Recent Development
  • 13.6 New England Biolabs
    • 13.6.1 New England Biolabs Company Details
    • 13.6.2 New England Biolabs Business Overview and Its Total Revenue
    • 13.6.3 New England Biolabs LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
    • 13.6.4 New England Biolabs Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2015-2020)
    • 13.6.5 New England Biolabs Recent Development
  • 13.7 Lucigen Corporation
    • 13.7.1 Lucigen Corporation Company Details
    • 13.7.2 Lucigen Corporation Business Overview and Its Total Revenue
    • 13.7.3 Lucigen Corporation LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
    • 13.7.4 Lucigen Corporation Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2015-2020)
    • 13.7.5 Lucigen Corporation Recent Development
  • 13.8 Merck
    • 13.8.1 Merck Company Details
    • 13.8.2 Merck Business Overview and Its Total Revenue
    • 13.8.3 Merck LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
    • 13.8.4 Merck Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2015-2020)
    • 13.8.5 Merck Recent Development
  • 13.9 Mast Group
    • 13.9.1 Mast Group Company Details
    • 13.9.2 Mast Group Business Overview and Its Total Revenue
    • 13.9.3 Mast Group LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
    • 13.9.4 Mast Group Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2015-2020)
    • 13.9.5 Mast Group Recent Development
  • 13.10 OptiGene
    • 13.10.1 OptiGene Company Details
    • 13.10.2 OptiGene Business Overview and Its Total Revenue
    • 13.10.3 OptiGene LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
    • 13.10.4 OptiGene Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2015-2020)
    • 13.10.5 OptiGene Recent Development
  • 13.11 CapitalBio
    • 10.11.1 CapitalBio Company Details
    • 10.11.2 CapitalBio Business Overview and Its Total Revenue
    • 10.11.3 CapitalBio LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
    • 10.11.4 CapitalBio Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2015-2020)
    • 10.11.5 CapitalBio Recent Development
  • 13.12 Weifang Kanghua Biotech Co.,Ltd
    • 10.12.1 Weifang Kanghua Biotech Co.,Ltd Company Details
    • 10.12.2 Weifang Kanghua Biotech Co.,Ltd Business Overview and Its Total Revenue
    • 10.12.3 Weifang Kanghua Biotech Co.,Ltd LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
    • 10.12.4 Weifang Kanghua Biotech Co.,Ltd Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2015-2020)
    • 10.12.5 Weifang Kanghua Biotech Co.,Ltd Recent Development
  • 13.13 CapitalBio
    • 10.13.1 CapitalBio Company Details
    • 10.13.2 CapitalBio Business Overview and Its Total Revenue
    • 10.13.3 CapitalBio LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
    • 10.13.4 CapitalBio Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2015-2020)
    • 10.13.5 CapitalBio Recent Development
  • 13.14 BGI
    • 10.14.1 BGI Company Details
    • 10.14.2 BGI Business Overview and Its Total Revenue
    • 10.14.3 BGI LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
    • 10.14.4 BGI Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2015-2020)
    • 10.14.5 BGI Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease status, future forecast, growth opportunity, key market and key players. The study objectives are to present the LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    CapitalBio
    BGI
    Eiken Chemical
    Deaou Biotechnology
    Singuway
    New England Biolabs
    Lucigen Corporation
    Merck
    Mast Group
    OptiGene
    CapitalBio
    Weifang Kanghua Biotech Co.,Ltd
    CapitalBio
    BGI

    Market segment by Type, the product can be split into
    by Pathogene
    Mycoplasma Pneumoniae
    Streptococcus Pneumoniae
    Haemophilus Influenzae
    Moraxella Catarrhalis
    Chlamydia Pneumoniae
    Klebsiella Pneumoniae
    Staphylococcus Aureus
    Others
    by Disease
    Cold
    Pharyngitis
    Bronchitis
    Tracheitis
    Pneumonia (Covid-19, CAP, etc.)
    Market segment by Application, split into
    Infant (<1 year old)
    Children and Adolescents (1-25 years old)
    Adult (25-65 years old)
    Senior citizens (over 65 years old)

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease status, future forecast, growth opportunity, key market and key players.
    To present the LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now